107 related articles for article (PubMed ID: 30256570)
21. Transforming growth factor-beta receptor types I and II in cultured porcine leydig cells: expression and hormonal regulation.
Goddard I; Bouras M; Keramidas M; Hendrick JC; Feige JJ; Benahmed M
Endocrinology; 2000 Jun; 141(6):2068-74. PubMed ID: 10830292
[TBL] [Abstract][Full Text] [Related]
22. Reduced transforming growth factor-beta type II receptor (TGF-beta RII) expression in adenocarcinoma of the lung.
Kim WS; Park C; Jung YS; Kim HS; Han J; Park CH; Kim K; Kim J; Shim YM; Park K
Anticancer Res; 1999; 19(1A):301-6. PubMed ID: 10226558
[TBL] [Abstract][Full Text] [Related]
23. HSP47 Promotes Glioblastoma Stemlike Cell Survival by Modulating Tumor Microenvironment Extracellular Matrix through TGF-β Pathway.
Jiang X; Zhou T; Wang Z; Qi B; Xia H
ACS Chem Neurosci; 2017 Jan; 8(1):128-134. PubMed ID: 27696866
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of ribosomal protein S15A induces human glioblastoma cell apoptosis.
Zhang C; Fu J; Xue F; Ryu B; Zhang T; Zhang S; Sun J; Xu X; Shen Z; Zheng L; Chen X
World J Surg Oncol; 2016 Apr; 14():129. PubMed ID: 27130037
[TBL] [Abstract][Full Text] [Related]
25. Increased transforming growth factor-β2 in epidermal growth factor receptor variant III-positive glioblastoma.
Zhang X; Wu A; Fan Y; Wang Y
J Clin Neurosci; 2011 Jun; 18(6):821-6. PubMed ID: 21511480
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of the AKT3 (PKBγ), PI3KCA, and VEGFR2 genes by RNA interference suppresses glioblastoma multiforme T98G cells invasiveness in vitro.
Paul-Samojedny M; Pudełko A; Suchanek-Raif R; Kowalczyk M; Fila-Daniłow A; Borkowska P; Kowalski J
Tumour Biol; 2015 May; 36(5):3263-77. PubMed ID: 25501707
[TBL] [Abstract][Full Text] [Related]
27. The role of AKT isoforms in glioblastoma: AKT3 delays tumor progression.
Joy A; Kapoor M; Georges J; Butler L; Chang Y; Li C; Crouch A; Smirnov I; Nakada M; Hepler J; Marty M; Feuerstein BG
J Neurooncol; 2016 Oct; 130(1):43-52. PubMed ID: 27422127
[TBL] [Abstract][Full Text] [Related]
28. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
[TBL] [Abstract][Full Text] [Related]
29. Decreased transforming growth factor beta type II receptor expression in intestinal adenomas from Min/+ mice is associated with increased cyclin D1 and cyclin-dependent kinase 4 expression.
Zhang T; Nanney LB; Peeler MO; Williams CS; Lamps L; Heppner KJ; DuBois RN; Beauchamp RD
Cancer Res; 1997 May; 57(9):1638-43. PubMed ID: 9134999
[TBL] [Abstract][Full Text] [Related]
30. [Activation of formylpeptide receptor in human malignant glioma cells and its effects on cell proliferation and production of angiogenic factors].
Yao XH; Bian XW; Ping YF; Chen JH; Wang QL; Jiang XF
Ai Zheng; 2007 Mar; 26(3):241-6. PubMed ID: 17355784
[TBL] [Abstract][Full Text] [Related]
31. EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor beta type II receptor gene.
Im YH; Kim HT; Lee C; Poulin D; Welford S; Sorensen PH; Denny CT; Kim SJ
Cancer Res; 2000 Mar; 60(6):1536-40. PubMed ID: 10749119
[TBL] [Abstract][Full Text] [Related]
32. [Human antigen R regulates TGF-β
Wang N; Yan D; Gu XM; Liu Y; Jiang SJ
Zhonghua Yi Xue Za Zhi; 2016 Oct; 96(38):3078-3082. PubMed ID: 27784449
[No Abstract] [Full Text] [Related]
33. Efficacy of Combination Therapy with MET and VEGF Inhibitors for MET-overexpressing Glioblastoma.
Okuda T; Tasaki T; Nakata S; Yamashita K; Yoshioka H; Izumoto S; Kato A; Fujita M
Anticancer Res; 2017 Jul; 37(7):3871-3876. PubMed ID: 28668888
[TBL] [Abstract][Full Text] [Related]
34. Mycophenolic acid inhibits the autocrine PDGF-B synthesis and PDGF-BB-induced mRNA expression of Egr-1 in rat mesangial cells.
Sabuda-Widemann D; Grabensee B; Schwandt C; Blume C
Nephrol Dial Transplant; 2009 Jan; 24(1):52-61. PubMed ID: 18723570
[TBL] [Abstract][Full Text] [Related]
35. [Effects of endostatin pretreatment on fibrosis of human skin fibroblasts and the mechanisms].
Ren HT; Li Y; Wang SD; Han CM
Zhonghua Shao Shang Za Zhi; 2017 Nov; 33(11):694-698. PubMed ID: 29166712
[No Abstract] [Full Text] [Related]
36. [Regulatory effect of small interfering RNA targeting multidrug resistant protein 1 on chemosensitivity of human multiforme glioblastoma cell line BT325].
Zhao P; Zhang YZ; Sun MZ
Ai Zheng; 2005 Dec; 24(12):1436-41. PubMed ID: 16351788
[TBL] [Abstract][Full Text] [Related]
37. Platelet-derived growth factor receptor independent proliferation of human glioblastoma cells: selective tyrosine kinase inhibitors lack antiproliferative activity.
Gross D; Bernhardt G; Buschauer A
J Cancer Res Clin Oncol; 2006 Sep; 132(9):589-99. PubMed ID: 16736141
[TBL] [Abstract][Full Text] [Related]
38. Mutation analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic human colon cancer using genomic DNA and intron primers.
Takenoshita S; Tani M; Nagashima M; Hagiwara K; Bennett WP; Yokota J; Harris CC
Oncogene; 1997 Mar; 14(10):1255-8. PubMed ID: 9121777
[TBL] [Abstract][Full Text] [Related]
39. Glioma-Derived Platelet-Derived Growth Factor-BB Recruits Oligodendrocyte Progenitor Cells via Platelet-Derived Growth Factor Receptor-α and Remodels Cancer Stroma.
Zheng Y; Yamamoto S; Ishii Y; Sang Y; Hamashima T; Van De N; Nishizono H; Inoue R; Mori H; Sasahara M
Am J Pathol; 2016 May; 186(5):1081-91. PubMed ID: 26945107
[TBL] [Abstract][Full Text] [Related]
40. [Effects of FPR2 gene silencing on the proliferation, migration and invasion of human glioma U87 cells].
Liu L; Li X; Shi J; Li L; Wang J; Luo ZZ
Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):659-666. PubMed ID: 30293389
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
